Verastem (VSTM) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $44.7 million.

  • Verastem's Accumulated Expenses rose 10187.33% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 10187.33%. This contributed to the annual value of $26.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Verastem reported Accumulated Expenses of $44.7 million as of Q3 2025, which was up 10187.33% from $38.1 million recorded in Q2 2025.
  • Verastem's 5-year Accumulated Expenses high stood at $44.7 million for Q3 2025, and its period low was $8.8 million during Q1 2021.
  • In the last 5 years, Verastem's Accumulated Expenses had a median value of $16.0 million in 2021 and averaged $19.1 million.
  • Per our database at Business Quant, Verastem's Accumulated Expenses tumbled by 5109.38% in 2021 and then soared by 12178.54% in 2025.
  • Quarter analysis of 5 years shows Verastem's Accumulated Expenses stood at $15.6 million in 2021, then dropped by 4.08% to $15.0 million in 2022, then grew by 8.88% to $16.3 million in 2023, then skyrocketed by 59.08% to $26.0 million in 2024, then skyrocketed by 72.32% to $44.7 million in 2025.
  • Its last three reported values are $44.7 million in Q3 2025, $38.1 million for Q2 2025, and $25.4 million during Q1 2025.